23 February 2021 at 10.00 am local time (EET)
Biohit Oyj: Managers' Transactions
Person subject to the notification requirement
Name: Semi Korpela
Position: Chief Executive Officer
Issuer: Biohit Oyj
LEI: 74370089ATTSNBXJVT29
__________________________________________________
Notification type: INITIAL NOTIFICATION
Reference number: 74370089ATTSNBXJVT29_20210222152942_7
Transaction date: 2021-02-19
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: DISPOSAL
Instrument type: SHARE
ISIN: FI0009005482
Transaction details
Volume: 6,217
Unit price: 2.1559 EUR
Aggregated transactions
Volume: 6,217
Volume weighted average price: 2.1559 EUR
Biohit Oyj
Semi Korpela
CEO
For additional information:
CEO Semi Korpela,
Biohit Oyj
p. +358 9 773 861
investor.relations@biohit.fi
www.biohit.fi
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and services
to promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share
(BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com